InvestorsHub Logo
Followers 91
Posts 11358
Boards Moderated 0
Alias Born 06/06/2014

Re: None

Sunday, 01/27/2019 11:41:31 AM

Sunday, January 27, 2019 11:41:31 AM

Post# of 403090
Article in WSJ today about Pfizer going deeper into cancer therapies. The question with Kevetrin is, was the abbreviated Phase 2A (only two patients) adequate for clinical evidence for the BP that expressed serious interest. Our management is hopeful but that remains to be seen. If we get capital, we will likely finish the K pill this year and commence a Phase 1B/2A with it.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News